[Therapeutic choices of penile erectile dysfunction].
OBJECTIVE
To discuss the therapeutic choices of erectile dysfunction (ED) and to improve the therapeutic efficacy for different ED cases.


METHODS
Two hundred and twenty-seven patients with ED were treated repectively with psychological treatment(31 cases), oral testosterone(30 cases), Viagra(121 cases), psychological treatment + Viagra (16 cases), intraurethral PGE1 (8 cases) and intracavemous injection(21 cases).


RESULTS
Among those ED patients, 142 (62.6%) cases reported improved erections after they had undergone above-mentioned therapies. The improved patients include 12 cases(38.7%) with psychological treatment, 9 cases (30.0%) with oral testosterone, 91 cases (75.2%) with Viagra, 13 cases (81.3%) with psychological and Viagar, 2 cases (25.0%) with intraurethral PGE1 and 21 cases (71.4%) with intracavemous injection.


CONCLUSIONS
ED is a highly individualized disease, therapeutic choices of ED based on patient's situation can benefit those patients.
Bai
Wen-Jun
WJ
Department of Urology, Peking University, People's Hospital, Beijing 100044, China.
Wang
Xiao-Feng
XF
Jiang
Xi-Tao
XT
Qu
Hong-Wei
HW
Zhu
Ji-Chuan
JC
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000527:Alprostadil / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D011613:Psychotherapy; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D013739:Testosterone / Q000627:therapeutic use*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D013739:Testosterone; D000068677:Sildenafil Citrate; D000527:Alprostadil